Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes

Genes and Development

Volumn 9, Issue 11, 1995, Pages 1340-1353

  Beijersbeigen, Roderick L ^a   Cariée, Leone ^a   Kerkhoven, Ron M ^a   Bernards, René ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Cell cycle; cyclin dependent kinase; cyclins; E2F; p107

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLINE; PROTEIN; PROTEIN P107; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL STRAIN 3T3; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0029031349     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.9.11.1340     Document Type: Article

References (66)

1. Ajchembaum, F., K. Ando, J.A. DeCaprio, and J.D. Griffin. 1993. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. J. Biol. Chem. 268: 4113-4119.
2. 1. Genes & Dev. 7: 812-821.
3. Bandara, L.R., V.M. Buck, M. Zamanian, L.H. Johnston, and N.B. La Thangue. 1993. Functional synergy between DP-1 and E2F-1 in the cell cycle regulating transcription factor DTRF1/E2F1. EMBO J. 12: 4317-4324.
4. Bates, S., D. Parry, L. Bonetta, K. Vousden, C. Dickson, and G. Peters. 1994. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene 9: 1633-1640.
5. Beijersbergen, R.L., E.M. Hijmans, L. Zhu, and R. Bernards. 1994a. Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation. EMBO J. 13: 4080-4086.
6. Beijersbergen, R.L., R. Kerkhoven, L. Zhu, L. Carlée, P.M. Voorhoeve, and R. Bernards. 1994b. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes & Dev. 8: 2680-2690.
7. Buchkovich, K., L.A. Duffy, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58: 1097-1105.
8. Cao, L., B. Faha, M. Dembski, L.H. Tsai, E. Harlow, and N. Dyson. 1992. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 355: 176-179.
9. Chellappan, S.P., S. Hiebert, M. Mudryj, J.M. Horowitz, and J.R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65: 1053-1061.
10. Chen, P.L., P. Scully, J.Y. Shew, J.Y. Wang, and W.H. Lee. 1989. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58: 1193-1198.
11. Cobrinik, D., P. Whyte, D.S. Peeper, T. Jacks, and R.A. Weinberg. 1993. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes & Dev. 7: 2392-2404.
12. DeCaprio, J.A., J.W. Ludlow, D. Lynch, Y. Furukawa, I. Griffin, H. Piwnica-Worms, C.-M. Huang, and D.M. Livingston. 1989. The product of the retinoblastoma gene has properties of a cell cycle regulatory element. Cell 58: 1085-1095.
13. Dowdy, F.D., P.W. Hinds, K. Louie, S.I. Reed, and R.A. Weinberg. 1993. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73: 499-511.
14. Dulic, V., E. Lees, and S.I. Reed. 1992. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257: 1958-1961.
15. Dynlacht, B.D., O. Flores, J.A. Lees, and E. Harlow. 1994. Differential regulation of E2F trans-activation by cyclin/cdk2 complexes. Genes & Dev. 8: 1772-1786.
16. Eilers, M., S. Schirm, and J.M. Bishop. 1991. The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J. 10: 133-141.
17. Ewen, M.E., H.K. Sluss, C.J. Sherr, H. Matsushime, J. Kato, and D.M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73: 487-497.
18. Field, J., J.I. Nikawa, D. Broek, B. MacDonald, L. Rodgers, I.A. Wilson, R.A. Lerner, and M. Wigler. 1988. Purification of a ras-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol. Cell. Biol. 8: 2159-2165.
19. Ginsberg, D., G. Vairo, T. Chittenden, Z.-X. Xiao, G. Xu, K.L. Wydner, J.A. DeCaprio, J.B. Lawrence, and D.M. Livingston. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p 107. Genes & Dev. 8: 2665-2679.
20. Graham, F.L. and A.J. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456-467.
21. Gu, W., K. Bhatia, I.T. Magrath, C.V. Dang, and R. Dalla-Favera. 1994. Binding and suppression of the Myc transcriptional activation domain by p107. Science 264: 251-254.
22. Helin, K., C.-L. Wu, A.R. Fattaey, J.A. Lees, B.D. Dynlacht, C. Ngwu, and E. Harlow. 1993. Heterodimerization of the transcription factor E2F-1 and DP-1 leads to cooperative transactivation. Genes &. Dev. 7: 1850-1861.
23. Hijmans, E.M., P.M. Voorhoeve, R.L. Beijersbergen, and R. Bernards. 1995. E2F-5, a new E2F familiy member that interacts with p130 in vivo. Mol. Cell. Biol. (in press).
24. Hinds, P.W., S. Mittnacht, V. Dulic, A. Arnold, S.I. Reed, and R.A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70: 993-1006.
25. Hinds, P.W., S.F. Dowdy, E.N. Eaton, A. Arnold, and R.A. Weinberg. 1994. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. 91: 709-713.
26. Jiang, W., S.M. Kahn, N. Tomita, Y.J. Zhang, S.H. Lu, and I.B. Weinstein. 1992. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res. 52: 2980-2983.
27. Johnson, D.G., K. Ohtani, and J.R. Nevins. 1994. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes & Dev. 8: 1514-1525.
28. Kamb, A., N.A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S.V. Tavtigian, E. Stoclkert, R.S. Day, B.E. Johnson, and M.H. Skolnick. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440.
29. Kato, J., H. Matsushime, S.W. Hiebert, M.E. Ewen, and C.J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes & Dev. 7: 331-342.
30. Koff, A., A. Giordano, D. Desai, K. Yamashita, J.W. Harper, S. Elledge, T. Nishimoto, D.O. Morgan, B.R. Franza, and J.M. Roberts. 1992. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257: 1689-1694.
31. Krek, W., D.M. Livingston, and S. Shirodkar. 1993. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262: 1557-1560.
32. Krek, W., M.E. Ewen, S. Shirodkar, Z. Arany, W.G. Kaelin Jr., and D.M. Livingston. 1994. Negative regulation of the growth promoting transcription factor E2F-1 by a stably bound cyclin a-dependent protein kinase. Cell 78: 161-172.
33. Lammie, G.A., V. Fantl, R. Smith, E. Schuuring, S. Brookes, R. Michalides, C. Dickson, A. Arnold, and G. Peters. 1991. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamouse cell and mammary carcinoma and linked to BCL-1. Oncogene 6: 439-444.
34. Lees, E., B. Faha, V Dulic, S.I. Reed, and E. Harlow. 1992. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes & Dev 6: 1874-1885.
35. Lees, J.A., M. Saito, M. Vidai, M. Valentine, T. Look, E. Harlow, N. Dyson, and K. Helin. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13: 7813-7825.
36. Li, Y., C. Graham, S. Lacy, A.M.V. Duncan, and P. Whyte. 1993. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes & Dev. 7: 2366-2377.
37. Lovec, H., A. Sewing, F.C. Lucibello, R. Muller, and T. Moroy. 1994. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: Link between cell cycle control and malignant transformation. Oncogene 9: 323-326.
38. Ludlow, J.W., J.A. DeCaprio, C.M. Huang, W.H. Lee, E. Paucha and D.M. Livingston. 1989. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56: 57-65.
39. Lukas, J., M. Pagano, Z. Staskova, G. Draetta, and J. Bartek. 1994. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9: 707-718.
40. Matsushime, H., M.F. Roussel, R.A. Ashmun, and C.J. Sherr. 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65: 701-713.
41. Matsushime, H., D.E. Quelle, S.A. Shurtleff, M. Shibuya, C.J. Sherr, and J. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14: 2066-2076.
42. Motokura, T., T. Bloom, H.G. Kim, H. Juppner, J.V. Ruderman, H.M. Kronenberg, and A. Arnold. 1991. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350: 512-515.
43. 1 in mammalian fibroblasts. Science 259: 1908-1912.
44. Peters, G. 1994. Stifled by inhibitors. Nature 371: 204-205.
45. Polyak, K., M.H. Lee, B.H. Erdjument, A. Koff, J.M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
46. 1 phase in rodent fibroblaets. Genes & Dev. 7: 1559-1571.
47. Resnitzky, D., M. Gossen, H. Bujard, and S.I. Reed. 1994. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell Biol 14: 1669-1679.
48. Rosenberg, C.L., E. Wong, E.M. Petty, A.E. Bale, Y. Tsujimoto N.L. Harris, and A. Arnold. 1991. PRAD1, a candidate BCL1 oncogene: Mapping and expression in centrocytic lvmphoma. Proc. Natl. Acad. Sci. 88: 9638-9642.
49. Schuuring, E., E. Verhoeven, W.J. Mooi, and R.J. Michalides. 1992a. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7: 355-361.
50. Schuuring, E., E. Verhoeven, T.H. van, J.L. Peterse, B. Nunnink, F.B. Thunnissen, P. Devilee, C.J. Cornelisse, M.J. van de Vijver, W.J. Mooi et al. 1992b. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res. 52: 5229-5234.
51. Seed, B. and J.Y. Sheen. 1988. A simple phase-extaction assay for chloramphenicol acetyltransferase activity. Gene 67: 271-277.
52. Serrano, M., G. Hannon, and D. Beach. 1993. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/cdk4. Nature 366: 704-707.
53. Seto, M., K. Yamamoto, S. Iida, Y. Akao, K.R. Utsumi, I. Kubonishi, I. Miyoshi, T. Ohtsuki, Y. Yawata, M. Namba et al. 1992. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene 7: 1401-1406.
54. Sewing, A., C. Burger, S. Brusselbach, C. Schalk, F.C. Lucibello, and R. Muller. 1993. Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. J. Cell Sci. 104: 545-554.
55. Sherr, C.J. 1993. Mammalian G1 cyclins. Cell 73: 1059-1065.
56. Shirodkar, S., M. Ewen, J.A. DeCaprio, J. Morgan, D.M. Livingston, and T. Chittenden. 1992. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68: 157-166.
57. Tam, S.W., A.M. Theodoras, J.W. Shay, G.F. Draetta, and M. Pagano. 1994. Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with cdk4 is required for cyclin D1 function in G1 progression. Oncogene 9: 2663-2674.
58. Toyoshima, H. and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74.
59. Vairo, G., D.M. Livingston, and D. Ginsberg. 1995. Functional interaction between E2F-4 and p130: Evidence for distinct mechanismns underlying growth suppression by dfferent retinoblastoma protein family members. Genes & Dev. 9: 869-881.
60. van den Heuvel, S., and E. Harlow. 1993. Distinct roles for cyclin dependent kinases in cell cycle control. Science 262: 2050-2054.
61. Wang, T.C., R.D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E.V. Schmidt. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669-671.
62. Wimmel, A., F.C. Lucibello, A. Sewing, S. Adolph, and R. Muller. 1994. Inducible acceleration of G1progression through tetracycline-regulated expression of human cyclin E. Oncogene 9: 995-997.
63. Withers, D.A., R.C. Harvey, J.B. Faust, O. Melnyk, K. Carey, and T.C. Meeker. 1991. Characterization of a candidate bcl-1 gene. Mol. Cell. Biol. 11: 4846-4853.
64. Won, K.A., Y. Xiong, D. Beach, and M.Z. Gilman. 1992. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc. Natl. Acad. Sci. 89: 9910-9914.
65. Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes & Dev. 7: 1111-1125.
66. Zhu, L., G. Enders, J.A. Lees, R.L. Beijersbergen, R. Bernards, and E. Harlow. 1995. The pRb related protein p107 contains two growth suppression domains: Independent interactions with E2F and cyclin/cdk complexes. EMBO J. (in press).